And now you hit the nail on the head with the real problem.

New Post Public Reply Private Reply Replies (1) Message Board
Figgs cardamine #139436
662
And now you hit the nail on the head with the real problem. The real reason that the FDA needs to blame the SEC problem is what Dr. Jay mentioned: " we were 82 percent effective at day 14 with Covid, but the drug was no longer in the system after that time frame by the time we got to day 28." And that's what the FDA needs to CYA about, that's the real SEC cover, that if they had gone with LL instead of backing what they knew to be a useless drug in Remdesivir they might have saved a bunch of lives. That's why they kept the Covid hold on.

I emailed them repeatedly studies on Remdesivir that said it didn't work and that they should look at our 14 day results, all to no avail.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rice Kids and Sunaayy Foundation Join Forces to Transform Lives

Updated Category News Views 139

Rice Kids Collaborates with Sunaayy Foundation Youth-led nonprofit Rice Kids is teaming up with the Sunaayy Foundation to tackle the pressing challenges children face in accessing education. Mission-Driven Partnership This partnership is dedicated to breaking the cycles of poverty through innovative and comprehensive education programs aimed at underprivileged children....

Continue Reading
KellyOCG + Sevenstep Achieves Top Rankings in Global RPO Sector

Updated Category News Views 1204

KellyOCG + Sevenstep Achieves Prime Recognition in RPO Rankings TROY, Mich. - KellyOCG + Sevenstep, a prominent name in the field of permanent hiring outsourced solutions, has once again made a significant impact on the recruitment landscape. Recently, this collaboration has been celebrated as a leading provider in HRO Today’s Baker’s Dozen Customer Satisfaction...

Continue Reading
Tharimmune Boosts Board with Experienced Leaders for Growth

Updated Category News Views 121

Strengthening the Board of Directors at Tharimmune Tharimmune, Inc. (NASDAQ: THAR) is excited to announce the appointment of Jill Sommers and William Wiley to its Board of Directors. This decision comes as the company advances its Canton Network infrastructure, aiming for modernization and efficiency in the financial markets. Introducing Jill Sommers Jill Sommers is a...

Continue Reading
US Foods Announces Q3 2024 Financial Results Conference Call

Updated Category News Views 47

US Foods Hosting Q3 2024 Financial Results Call US Foods Holding Corp. (NYSE: USFD) has exciting news for investors and stakeholders. The company is set to host a live conference call and webcast on Thursday to delve into the financial results of the third quarter of 2024. The event will take place at 8 a.m. CST, offering a platform for sharing crucial insights and...

Continue Reading
Luxury Living Redefined: Parkside Apartments' Remarkable Sale

Updated Category News Views 162

Luxury Living Redefined with Parkside Apartments Sale Recently, a significant milestone was achieved in the realm of luxury real estate with the notable sale of Parkside Apartments for an impressive $286 million. This landmark transaction exemplifies the vibrant and dynamic nature of the housing market, particularly in a tech-centric region near Seattle. Parkside...

Continue Reading